BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33256620)

  • 41. Progressive Familial Intrahepatic Cholestasis.
    Bull LN; Thompson RJ
    Clin Liver Dis; 2018 Nov; 22(4):657-669. PubMed ID: 30266155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
    Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
    Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
    Al-Hussaini A; Lone K; Bashir MS; Alrashidi S; Fagih M; Alanazi A; AlYaseen S; Almayouf A; Alruwaithi M; Asery A
    J Pediatr; 2021 Sep; 236():113-123.e2. PubMed ID: 33915153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
    Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
    Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
    Sticova E; Jirsa M; Pawłowska J
    Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy.
    Siew SM; Cunningham SC; Zhu E; Tay SS; Venuti E; Bolitho C; Alexander IE
    Hepatology; 2019 Dec; 70(6):2047-2061. PubMed ID: 31099022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
    Andress EJ; Nicolaou M; McGeoghan F; Linton KJ
    Cell Mol Life Sci; 2017 Jul; 74(13):2513-2524. PubMed ID: 28220208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical and genetic analysis of a family affected by progressive familial intraphepatic cholestasis type 3].
    Deng M; Guo L; Song Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):686-690. PubMed ID: 30298496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
    Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
    De Masi R; Orlando S; De Donno A
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2347-2350. PubMed ID: 31568708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults.
    Cao L; Ling X; Yan J; Feng D; Dong Y; Xu Z; Wang F; Zhu S; Gao Y; Cao Z; Zhang M
    Orphanet J Rare Dis; 2024 Apr; 19(1):157. PubMed ID: 38610052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
    Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
    J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
    van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3].
    Cao LL; Yan JG; Feng DN; Dong Y; Xu ZQ; Wang FC; Gao YJ; Zhu SS; Zhang M
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):462-466. PubMed ID: 38623015
    [No Abstract]   [Full Text] [Related]  

  • 57. Ivacaftor-Mediated Potentiation of ABCB4 Missense Mutations Affecting Critical Motifs of the NBDs: Repositioning Perspectives for Hepatobiliary Diseases.
    Delaunay JL; Elbahnsi A; Bruneau A; Madry C; Durand-Schneider AM; Stary A; Housset C; Gautheron J; Callebaut I; Aït-Slimane T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
    Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
    Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.
    Sun HZ; Shi H; Zhang SC; Shen XZ
    World J Gastroenterol; 2015 Jan; 21(2):699-703. PubMed ID: 25593501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.